USE OF PYTHON AND COMPLETE BLOOD COUNT PARAMETERS FOR COST-EFFECTIVE THALASSEMIA SCREENING IN RESOURCE-LIMITED SETTINGS: DEVELOPMENT AND VALIDATION OF A SCREENING PROGRAM.
DOI:
https://doi.org/10.22159/ajpcr.2023.v16i10.48392Keywords:
Thalassemia Screening, erythrocyte indices, hemoglobin, Validation dataset, Spider Integrated Development EnvironmentAbstract
Objective: Thalassemia screening is typically performed using high-performance liquid chromatography (HPLC), which is an accurate but expensive method that is not widely available. To overcome this issue, researchers have looked into alternative screening methods such as using erythrocytic indices obtained from a complete blood count (CBC) test. This approach has proven to be highly sensitive and specific, making it an attractive and cost-effective solution for excluding normal populations from thalassemia screening programs. Consequently, it can improve the efficiency of screening programs, particularly in settings with limited resources.
Methods: We have developed a Python program based on a novel methodology aimed at effectively excluding normal populations from chromatography-based screening programs for thalassemia mutation screening. The program was implemented in Python 3.8 using the Spider Integrated Development Environment. It takes input parameters such as hemoglobin, red blood corpuscles, mean corpuscular volume, and hematocrit from CBC tests to determine an individual’s thalassemia status. To validate the program, we utilized a dataset of 3,000 students who had undergone CBC testing at a local clinic. To ensure privacy protection, the dataset was anonymized.
Results: Our study showed that CBC parameters accurately identified individuals with thalassemia through the Python program-based thalassemia screening approach with no false-positive samples. We validated its performance on a large dataset of students and found that it can improve screening efficiency and accuracy, particularly in resource-limited settings.
Conclusion: However, additional validation studies are necessary to confirm its generalizability and usefulness in diverse populations
Downloads
References
Colah R, Italia K, Gorakshakar A. Burden of thalassemia in India: The road map for control. Pediatr Hematol Oncol J 2017;2:79-84. doi: 10.1016/j.phoj.2017.10.002
Sinha S, Dutta AK, Bhattacharya P, Bhattacharya S, Das MK. Spectrum of rare and novel indel mutations responsible for β thalassemia in Eastern India. Ind J Clin Biochem 2023;1:7. doi: 10.1007/s12291-022- 01098-w.
Saputra DC, Sunat K, Ratnaningsih T. A new artificial intelligence approach using extreme learning machine as the potentially effective model to predict and analyze the diagnosis of anemia. Healthcare (Basel) 2023;11:697. doi: 10.3390/healthcare11050697, PMID 36900702
Ottolenghi S, Lanyon WG, Williamson R, Weatherall DJ, Clegg JB, Pitcher CS. Human globin gene analysis for a patient with beta-o/ delta beta-thalassemia. Proc Natl Acad Sci U S A 1975;72:2294-9. doi: 10.1073/pnas.72.6.2294, PMID 49057
Rustam F, Ashraf I, Jabbar S, Tutusaus K, Mazas C, Barrera AE, et al. Prediction of [formula: See text]-Thalassemia carriers using complete blood count features. Sci Rep 2022;12:19999. doi: 10.1038/s41598- 022-22011-8, PMID 36411295
Samanta A, Chaudhuri, Das PK, U, Bhattacharyya N. A new approach based on erythrocyte indices to exclude normal populations from chromatography based thalassemia screening programs with very high fidelity. Iran J Blood Cancer 2021;13:107-18.
Li N, Wu B, Wang J, Yan Y, An P, Li Y, et al. Differential proteomic patterns of plasma extracellular vesicles show potential to discriminate β-thalassemia subtypes. iScience 2023;26:106048. doi: 10.1016/j. isci.2023.106048, PMID 36824279
Published
How to Cite
Issue
Section
Copyright (c) 2023 Mr. Abhishek Samanta, Prof. (Dr.) Nandan Bhattacharyya
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.